W

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Business Management
Share
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Keystone breach deepens: Hackers stole key used to verify wallets as genuine

Keystone initially disclosed a leak of customer information but has since disclosed that hackers also stole a key that could allow counterfeit wallets to pass…

Ripple wins final US approval for national trust bank

The approval clears the way for Ripple to manage reserves backing its RLUSD stablecoin and provide digital asset custody. Source：Cointelegraph

Dividend stocks are having an excellent October as tech sector struggles

ETFs focused on dividend stocks are seeing a powerful rally in October, adding to huge gains in 2026. Source：MarketWatch

Options traders are seizing control of the S&P 500

There’s a reason the index hasn’t moved much since June, according to a team at UBS. Source：MarketWatch

Source：https://www.marketwatch.com/story/this-glp-1-drug-helped-people-maintain-their-weight-loss-in-a-clinical-trial-even-for-those-taking-it-once-a-month-f70929b5